JPRN-UMIN000022964已完成1 期
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancer - IRISOX for gemcitabine-refractory pancreatic cancer
Kitasato University School of Medicine0 个研究点目标入组 12 人开始时间: 2016年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with contraindication for the medication of Irinotecan, S-1 and L-OHP 2.History of serious drug hypersensitivity or a history of drug allergy 3.Pregnancy 4.Active infection 5.Severe complications (Grade 3,4 CTCAE v4.0) 6.Peripheral neuropathy(Grade 2,3,4 CTCAE v4.0) 7.Serious diarrhea(Grade 2,3,4 CTCAE v4.0) 8.Intestinal pneumonitis or pulmonary fibrosis 9.Much ascites or pleural effusion or pericardial effusion 10.Active double cancer 11.Symptomatic brain metastasis 12.Regular use of frucitocin, fenitoin or warfarin 13.Having UGT1A1*6/*6, UGT1A1*28/*28, or UGT1A1*6/*28 gene 14.Active Hepatitis B 15.Inappropriate for this study judged by the attending physician
研究者
相似试验
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
已完成
2 期
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20